Vanier MT - Search Results

1

Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase.

Hahn CN, del Pilar Martin M, Schröder M, Vanier MT, Hara Y, Suzuki K, Suzuki K, d'Azzo A. Hahn CN, et al. Among authors: vanier mt. Hum Mol Genet. 1997 Feb;6(2):205-11. doi: 10.1093/hmg/6.2.205. Hum Mol Genet. 1997. PMID: 9063740

2

Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.

Suzuki K, Vanier MT. Suzuki K, et al. Among authors: vanier mt. Dev Neurosci. 1991;13(4-5):288-94. doi: 10.1159/000112175. Dev Neurosci. 1991. PMID: 1840099 Review.

3

Gangliosidosis in emus (Dromaius novaehollandiae).

Bermudez AJ, Johnson GC, Vanier MT, Schröder M, Suzuki K, Stogsdill PL, Johnson GS, O'Brien D, Moore CP, Fry WW. Bermudez AJ, et al. Among authors: vanier mt. Avian Dis. 1995 Apr-Jun;39(2):292-303. Avian Dis. 1995. PMID: 7677649

4

Molecular analysis of the acid sphingomyelinase deficiency in a family with an intermediate form of Niemann-Pick disease.

Ferlinz K, Hurwitz R, Weiler M, Suzuki K, Sandhoff K, Vanier MT. Ferlinz K, et al. Among authors: vanier mt. Am J Hum Genet. 1995 Jun;56(6):1343-9. Am J Hum Genet. 1995. PMID: 7762557 Free PMC article.

5

Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa.

Vanier MT, Ferlinz K, Rousson R, Duthel S, Louisot P, Sandhoff K, Suzuki K. Vanier MT, et al. Hum Genet. 1993 Oct;92(4):325-30. doi: 10.1007/BF01247328. Hum Genet. 1993. PMID: 8225311

6

Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.

Fujita N, Suzuki K, Vanier MT, Popko B, Maeda N, Klein A, Henseler M, Sandhoff K, Nakayasu H, Suzuki K. Fujita N, et al. Among authors: vanier mt. Hum Mol Genet. 1996 Jun;5(6):711-25. doi: 10.1093/hmg/5.6.711. Hum Mol Genet. 1996. PMID: 8776585

7

Recent advances in elucidating Niemann-Pick C disease.

Vanier MT, Suzuki K. Vanier MT, et al. Brain Pathol. 1998 Jan;8(1):163-74. doi: 10.1111/j.1750-3639.1998.tb00143.x. Brain Pathol. 1998. PMID: 9458174 Free PMC article. Review.

8

Induced mouse models of abnormal sphingolipid metabolism.

Suzuki K, Vanier MT. Suzuki K, et al. Among authors: vanier mt. J Biochem. 1998 Jul;124(1):8-19. doi: 10.1093/oxfordjournals.jbchem.a022101. J Biochem. 1998. PMID: 9644238 Free article. Review.

9

Drastically abnormal gluco- and galactosylceramide composition does not affect ganglioside metabolism in the brain of mice deficient in galactosylceramide synthase.

Suzuki K, Vanier MT, Coetzee T, Popko B. Suzuki K, et al. Among authors: vanier mt. Neurochem Res. 1999 Apr;24(4):471-4. doi: 10.1023/a:1022571410445. Neurochem Res. 1999. PMID: 10227678

10

Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.

Tohyama J, Oya Y, Ezoe T, Vanier MT, Nakayasu H, Fujita N, Suzuki K. Tohyama J, et al. Among authors: vanier mt. J Inherit Metab Dis. 1999 Jun;22(5):649-62. doi: 10.1023/a:1005590316064. J Inherit Metab Dis. 1999. PMID: 10399097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page